ZA958789B - Diagnostic imaging agent - Google Patents

Diagnostic imaging agent

Info

Publication number
ZA958789B
ZA958789B ZA958789A ZA958789A ZA958789B ZA 958789 B ZA958789 B ZA 958789B ZA 958789 A ZA958789 A ZA 958789A ZA 958789 A ZA958789 A ZA 958789A ZA 958789 B ZA958789 B ZA 958789B
Authority
ZA
South Africa
Prior art keywords
imaging agent
diagnostic imaging
diagnostic
agent
imaging
Prior art date
Application number
ZA958789A
Other languages
English (en)
Inventor
Yuji Hashiguchi
Hideki Sugino
Kenji Kamimura
Shigemi Seri
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of ZA958789B publication Critical patent/ZA958789B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA958789A 1994-10-21 1995-10-18 Diagnostic imaging agent ZA958789B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28280094 1994-10-21

Publications (1)

Publication Number Publication Date
ZA958789B true ZA958789B (en) 1996-05-29

Family

ID=17657261

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958789A ZA958789B (en) 1994-10-21 1995-10-18 Diagnostic imaging agent

Country Status (11)

Country Link
US (1) US5863518A (sv)
EP (1) EP0707857A1 (sv)
KR (1) KR100343313B1 (sv)
AU (1) AU688119B2 (sv)
CA (1) CA2160819A1 (sv)
FI (1) FI954967A (sv)
IL (1) IL115670A (sv)
NO (2) NO305438B1 (sv)
NZ (1) NZ280272A (sv)
TW (1) TW522017B (sv)
ZA (1) ZA958789B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000086538A (ja) * 1998-09-17 2000-03-28 Toshihiro Akaike Ｍｒｉ用造影剤
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
DE10040381C1 (de) * 2000-08-11 2002-06-06 Schering Ag Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
US6641797B2 (en) 2000-08-11 2003-11-04 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
IL145723A0 (en) * 2000-10-11 2002-07-25 Nihon Mediphysics Co Ltd Process for producing an amide compound
US20030050452A1 (en) * 2000-12-26 2003-03-13 Yuji Hashiguchi Process for producing metal complex of aminooligosaccharide derivative
CN100382847C (zh) * 2005-02-05 2008-04-23 四川大学 用于影像诊断的配合体化合物及制备方法和影像诊断用化合物及其制备中间体
CN101619106B (zh) * 2009-08-17 2012-07-04 武汉工程大学 多糖类大分子顺磁性金属配合物及其合成方法和用途
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
JP7034160B2 (ja) 2016-11-28 2022-03-11 バイエル・ファルマ・アクティエンゲゼルシャフト 磁気共鳴画像法に使用するための高緩和度ガドリニウムキレート化合物
PE20211471A1 (es) 2018-11-23 2021-08-05 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666697A (en) * 1982-12-08 1987-05-19 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic agent
GB8413849D0 (en) * 1984-05-31 1984-07-04 Amersham Int Plc Nmr contrast agents
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
EP0184899B1 (en) * 1984-11-01 1990-04-18 Nycomed As Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation
GB8522535D0 (en) * 1985-09-11 1985-10-16 Amersham Int Plc Contrast agent
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
US4822594A (en) * 1987-01-27 1989-04-18 Gibby Wendell A Contrast enhancing agents for magnetic resonance images
DE3724188C2 (de) * 1987-07-17 1995-05-18 Heinz Dr Gries Metallhaltige Oligosaccharid-Polysulfate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
JP2871822B2 (ja) * 1989-08-29 1999-03-17 玉造株式会社 末端に２，５―アンヒドロマンニトール基または２，５―アンヒドロマンノース基を有するキチン・キトサンオリゴマーおよびその製造方法
JP2901787B2 (ja) * 1991-07-15 1999-06-07 日本メジフィジックス株式会社 核磁気共鳴造影剤
JP2894879B2 (ja) * 1991-10-04 1999-05-24 日本メジフィジックス株式会社 診断用造影剤
EP0563013B1 (de) * 1992-03-27 1997-04-23 Ciba SC Holding AG N-Substituierte Chitosanderivate, ein Verfahren zu deren Herstellung und deren Verwendung
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images
JP2786389B2 (ja) * 1993-05-18 1998-08-13 玉造株式会社 腫瘍免疫治療剤
ATE199550T1 (de) * 1993-12-30 2001-03-15 Guerbet Sa Polyaminierte liganden, metallkomplexe, verfahren zur herstellung und diagnostische und therapeutische verwendungen

Also Published As

Publication number Publication date
KR100343313B1 (ko) 2002-10-31
TW522017B (en) 2003-03-01
NO982233L (no) 1996-04-22
IL115670A (en) 1999-11-30
FI954967A0 (sv) 1995-10-18
NO312579B1 (no) 2002-06-03
KR960013388A (ko) 1996-05-22
FI954967A (sv) 1996-04-22
NO954183L (no) 1996-04-22
NZ280272A (en) 1996-11-26
EP0707857A1 (en) 1996-04-24
AU688119B2 (en) 1998-03-05
AU3436295A (en) 1996-05-02
NO982233D0 (no) 1998-05-15
IL115670A0 (en) 1996-01-19
US5863518A (en) 1999-01-26
NO954183D0 (no) 1995-10-19
CA2160819A1 (en) 1996-04-22
NO305438B1 (no) 1999-05-31

Similar Documents

Publication Publication Date Title
AU2276495A (en) Contrast agents for diagnostic imaging
AU5864296A (en) Diagnostic imaging x-ray contrast agents
ZA955642B (en) Lyophilized imaging agent formulation
GB9701274D0 (en) Ultrasound contrast imaging
GB2293651B (en) Medical untrasound imaging
EP0757696A4 (en) DIAGNOSIS OF HUMAN SPERM
GB9404335D0 (en) Vehicle diagnostic apparatus
GB2296565B (en) Ultrasound imaging
IL115670A (en) Diagnostic imaging agent
ZA976891B (en) Diagnostic imaging contrast agent.
IL110538A0 (en) Tomographic imaging system
ZA976889B (en) Diagnostic imaging contrast agent.
GB9710561D0 (en) Non-invasive diagnostic equipment
AU692590C (en) Diagnostic imaging agent
GB2328507B (en) Diagnostic apparatus
PL56039Y1 (en) Integrated diagnostic set
GB9417912D0 (en) Diagnostic apparatus
AU699499C (en) Diagnostic imaging agent
GB2301666B (en) Diagnostic device
AU3318995A (en) Diagnostic imaging agent
GB9402425D0 (en) Diagnostic technique
GB9402427D0 (en) Diagnostic technique
IL119777A0 (en) Diagnostic imaging device
GB9412381D0 (en) Imaging arrangements
GB9424142D0 (en) Imaging technique